Grant: Operating Grant - PA: Institute of Genetics (Bridge Funding)
McGill University
$100,000.00
Integrin-mediated signal transduction in mammary tumourigenesis and metastasis
EF 2011-12
Résumé
The major objective of this proposal is to evaluate the contribution of a class of receptors known as integrins that are expressed on surface of the cancer cell to their ability to spread to different organ sites. We will also evaluate using a number of well-defined mouse models whether these integrin receptors are involved in the phenomenon of tumour dormancy. This is a central issue in cancer biology in that it is recognized that although many normal patients harbor cancer cells, only 1% of these go on to develop clinical cancer due to the fact that many these cancer cells remain in a dormant state. The results of these studies will lead to the development of more effective therapeutic strategies to treat breast cancer patients.
Programme
Operating Grant - PA: Institute of Genetics (Bridge Funding)
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
249551
Name
Muller William J
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Molecular & Cellular Biology of Cancer
Projecttitle
Integrin-mediated signal transduction in mammary tumourigenesis and metastasis
Programtype2
Operating Grants
Orgnameinp2
McGill University
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Operating Grant - PA: Institute of Genetics (Bridge Funding)
Keyworddelim
Breast Cancer; Egfr Family; Erbb2; Integrins; Metastasis
Abstract
The major objective of this proposal is to evaluate the contribution of a class of receptors known as integrins that are expressed on surface of the cancer cell to their ability to spread to different organ sites. We will also evaluate using a number of well-defined mouse models whether these integrin receptors are involved in the phenomenon of tumour dormancy. This is a central issue in cancer biology in that it is recognized that although many normal patients harbor cancer cells, only 1% of these go on to develop clinical cancer due to the fact that many these cancer cells remain in a dormant state. The results of these studies will lead to the development of more effective therapeutic strategies to treat breast cancer patients.
Competitiondate
201109
Approvedterm2
1 yr 0 mth
Pinamesdelim
Muller, William J
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~